TCR-T Immunotherapy: The Challenges and Solutions

T cell receptor-engineered T cell (TCR-T) therapy is free from the limit of surface antigen expression of the target cells, which is a potential cellular immunotherapy for cancer treatment. Significant advances in the treatment of hematologic malignancies with cellular immunotherapy have aroused the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yating, Yan, Xin, Zhang, Fan, Zhang, Xiaoxia, Tang, Futian, Han, Zhijian, Li, Yumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822241/
https://www.ncbi.nlm.nih.gov/pubmed/35145905
http://dx.doi.org/10.3389/fonc.2021.794183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822241/
https://www.ncbi.nlm.nih.gov/pubmed/35145905
http://dx.doi.org/10.3389/fonc.2021.794183

Ejemplares similares